Yamashita Health Care Holdings,Inc. (9265.T)
JPY 2425.0
(1.93%)
JPY 2425.0
(1.93%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 878 Million | 2.16 Billion | 581.26 Million | 911.52 Million | 817.81 Million | -101.46 Million |
| Net Income | 580 Million | 635 Million | 1.02 Billion | 1.05 Billion | 642.32 Million | 382 Million |
| Depreciation & Amortization | 213 Million | 203 Million | 221.62 Million | 198.28 Million | 190.9 Million | 211.33 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 169 Million | 1.84 Billion | -190.46 Million | -182.41 Million | 146.73 Million | -571.66 Million |
| Other non-cash items | 209 Million | -516 Million | -475.4 Million | -155.89 Million | -162.14 Million | -123.13 Million |
| Investing Cash Flow | -1.06 Billion | -107 Million | -27.66 Million | -134.14 Million | -33.53 Million | 49.96 Million |
| Investments in PPE | -77 Million | -81 Million | -118.56 Million | -146.23 Million | -51.21 Million | -63.78 Million |
| Acquisitions | 7 Million | -30 Million | 100.17 Million | -9.05 Million | -3.9 Million | -10.03 Million |
| Investment purchases | -34 Million | -4 Million | -333.9 Million | -3.72 Million | -34.78 Million | -14.88 Million |
| Sales/Maturities of investments | 44 Million | 1 Million | 300 Million | 8.15 Million | 8.15 Million | 128.27 Million |
| Other Investing Activities | -1 Billion | 7 Million | 24.63 Million | 16.71 Million | 48.21 Million | 10.38 Million |
| Financing Cash Flow | -335 Million | -209 Million | -229.99 Million | -137.81 Million | -107.24 Million | -366.39 Million |
| Debt repayment | -48 Million | - | - | - | - | -300 Million |
| Dividends payments | -122 Million | -209 Million | -229.99 Million | -137.81 Million | -107.18 Million | -66.35 Million |
| Common Stock Repurchased | -165 Million | - | - | -64 Thousand | -64 Thousand | -31 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -30 Million | - | - | 64 Thousand | -1000.00 | -1000.00 |
| Accounts receivables | -424 Million | 1.41 Billion | 247 Million | -2 Billion | 6 Million | -118 Million |
| Accounts payables | 603 Million | 577 Million | -604.9 Million | 2.08 Billion | 295.05 Million | -396.87 Million |
| Inventory | -46 Million | -205 Million | 241.12 Million | -200.73 Million | -258.32 Million | -190.11 Million |
| Other working capital | 36 Million | 58 Million | -73.67 Million | -58.36 Million | 104 Million | 133.31 Million |
| Cash at beginning of period | 5.82 Billion | 3.97 Billion | 3.65 Billion | 3.01 Billion | 2.33 Billion | 2.75 Billion |
| Cash at end of period | 5.3 Billion | 5.82 Billion | 3.97 Billion | 3.65 Billion | 3.01 Billion | 2.33 Billion |
| Capital Expenditure | -77 Million | -81 Million | -118.56 Million | -146.23 Million | -51.21 Million | -63.78 Million |
| Effect of forex changes on cash | - | - | -1000.00 | - | - | - |
| Net cash flow / Change in cash | -525 Million | 1.85 Billion | 323.6 Million | 639.57 Million | 677.03 Million | -417.89 Million |
| Free Cash Flow | 801 Million | 2.08 Billion | 462.7 Million | 765.29 Million | 766.6 Million | -165.25 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 83 Million | 580 Million | 138 Million | -38 Million | 318 Million | 162 Million |
| Depreciation & Amortization | - | 213 Million | - | - | 51 Million | 47 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 169 Million | - | - | - | - |
| Other non-cash items | -83 Million | 209 Million | -138 Million | 38 Million | -318 Million | -162 Million |
| Investing Cash Flow | - | -1.06 Billion | - | - | - | - |
| Investments in PPE | - | -77 Million | - | - | - | - |
| Acquisitions | - | 7 Million | - | - | - | - |
| Investment purchases | - | -34 Million | - | - | - | - |
| Sales/Maturities of investments | - | 44 Million | - | - | - | - |
| Other Investing Activities | - | -1 Billion | - | - | - | - |
| Financing Cash Flow | - | -335 Million | - | - | - | - |
| Debt repayment | - | -48 Million | - | - | - | - |
| Dividends payments | - | -122 Million | - | - | - | - |
| Common Stock Repurchased | - | -165 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -30 Million | - | - | - | - |
| Accounts receivables | - | -424 Million | - | - | - | - |
| Accounts payables | - | 603 Million | - | - | - | - |
| Inventory | - | -46 Million | - | - | - | - |
| Other working capital | - | 36 Million | - | - | - | - |
| Cash at beginning of period | - | 5.82 Billion | - | - | 3.53 Billion | 5.82 Billion |
| Cash at end of period | - | 5.3 Billion | - | - | 5 Billion | 3.53 Billion |
| Capital Expenditure | - | -77 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -525 Million | - | - | 1.46 Billion | -2.29 Billion |
| Free Cash Flow | - | 801 Million | - | - | 102 Million | 94 Million |
MAQCW
MEDANTA
4726
8927
600237
002493